Kedrion Expands Ryplazim Distribution Network for PLGD-1 Patients [Yahoo! Finance]
CVS Health Corporation (CVS)
Last cvs health corporation earnings: 2/12 06:45 am
Check Earnings Report
US:NYSE Investor Relations:
investors.cvshealth.com
Company Research
Source: Yahoo! Finance
indicated for treating patients with plasminogen deficiency type 1 (PLGD-1). This expansion ensures timely access to this vital medication for patients across the US. PLGD-1 is a serious condition causing abnormal fibrin-rich lesions on mucosal surfaces, potentially leading to severe consequences like vision and hearing loss, airway obstruction, and infertility. Ryplazim, the only FDA approved therapy for PLGD-1 patients, offers an important treatment option. The recent FDA approval of the technology transfer and manufacturing capacity expansion of Ryplazim has enabled Kedrion to broaden its limited distribution network due to the increase of supply. This crucial step means more patients can have access to this treatment. The expanded network
Read more
Impact Snapshot
Event Time:
CVS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CVS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CVS alerts
High impacting CVS Health Corporation news events
Weekly update
A roundup of the hottest topics
CVS
News
- Why the Market Dipped But CVS Health (CVS) Gained Today [Yahoo! Finance]Yahoo! Finance
- Market Pullback After a Historic Rally: What Investors Should Do Now [Yahoo! Finance]Yahoo! Finance
- CVS Health Co. (NYSE: CVS) had its price target raised by analysts at Piper Sandler from $72.00 to $74.00. They now have an "overweight" rating on the stock.MarketBeat
- CVS Health Stock Soars. Profit, Sales Growth Need Repair. [Yahoo! Finance]Yahoo! Finance
- Daily Dividend Report: Darden, BXP, FirstEnergy, CVS Health, APLE [Forbes]Forbes
CVS
Earnings
- 2/12/25 - Beat
CVS
Sec Filings
- 3/18/25 - Form 4
- 3/14/25 - Form 4
- 3/7/25 - Form 4
- CVS's page on the SEC website